Anti-tim-3 antigen antibody or antibody derivative, and use thereof
US-2024391997-A1 · Nov 28, 2024 · US
US2018016352A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018016352-A1 |
| Application number | US-201615548942-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 5, 2016 |
| Priority date | Feb 5, 2015 |
| Publication date | Jan 18, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are targeting constructs for targeting a target site, including a molecule or complex of interest. The targeting constructs comprise a polymer chain and a plurality of multi-specific molecules each of which includes an affinity moiety for binding with the polymer chain and a targeting ligand for binding with the target site. The polymer chain may be associated with a therapeutic or diagnostic agent and generally comprises a plurality of sites, wherein individual sites bind with a multi-specific molecule of the target construct. The present disclosure also relates to methods of preparing the targeting construct and to its use in therapeutic and diagnostic applications.
Opening claim text (preview).
1 . A targeting construct represented by formula (I): p-[α-L-λ] n (I) wherein: p represents a polymer chain; α-L-λ, independently for each occurrence, represents a multi-specific molecule, wherein: α, independently for each occurrence, represents an affinity moiety that binds with the polymer chain; L, independently for each occurrence, is absent or represents a linker group; and λ, independently for each occurrence, represents a targeting ligand; and n represents an integer of at least 2, wherein the polymer chain comprises a plurality of affinity moiety-binding partners, wherein individual affinity moiety-binding partners bind with the affinity moiety of a respective multi-specific molecule. 2 . A targeting construct according to claim 1 , wherein the affinity moiety-binding partners are the same. 3 . A targeting construct according to claim 1 , wherein the affinity moiety-binding partners are different. 4 . A targeting construct according to claim 1 , wherein an individual affinity moiety-binding partner comprises or is formed by one or more groups of at least one monomer residue of the polymer chain. 5 . A targeting construct according to claim 1 , wherein a first affinity moiety-binding partner comprises or is formed by one or more groups of at least one first monomer residue of the polymer chain and wherein a second affinity moiety-binding partner comprises or is formed by one or more groups of at least one second monomer residue of the polymer chain. 6 . A targeting construct according to claim 5 , wherein the first monomer residue and the second monomer residue are different. 7 . A targeting construct according to claim 6 , wherein the first monomer residue and the second monomer residue are the same and wherein the one or more groups of the first monomer residue are different to the one or more groups of the second monomer residue. 8 . A targeting construct according to claim 5 , wherein the first affinity moiety-binding partner binds with a first affinity moiety of the construct and wherein the second affinity moiety-binding partner binds with a second affinity moiety of the construct, whereby the first affinity moiety and the second affinity moiety are different. 9 . A targeting construct according to claim 1 , wherein an individual affinity moiety-binding partner comprises an end group of the polymer chain. 10 . A targeting construct according to claim 1 , wherein an individual affinity moiety-binding partner comprises a pendant group of the polymer chain. 11 . A targeting construct according to claim 1 , wherein the polymer chain is a homopolymer. 12 . A targeting construct according to claim 1 , wherein the polymer chain is a copolymer. 13 . A targeting construct according to claim 12 , wherein the copolymer is selected from a statistical copolymer, a random copolymer, an alternating copolymer, a periodic copolymer, a block copolymer, a radial copolymer, a graft copolymer, or combination thereof. 14 . A targeting construct according to claim 1 , wherein the polymer chain is linear. 15 . A targeting construct according to claim 1 , wherein the polymer chain is a non-linear polymer. 16 . A targeting construct according to claim 15 , wherein the non-linear polymer chain is selected from branched polymers, brush polymers, star polymers, comb polymers, dendrimer polymers, network polymers, cross-linked polymers, semi-cross-linked polymers, graft polymers, and combinations thereof. 17 . A targeting construct according to claim 15 , wherein the non-linear polymer comprises pendant cognate binding partners, individual ones of which bind with an affinity moiety of the targeting construct. 18 . A targeting construct according to claim 1 , wherein the polymer chain is crosslinked with another polymer chain. 19 . A targeting construct according to claim 1 , wherein the polymer chain comprises monomer residues derived from butadienes, styrenes, propene, acrylates, methacrylates, vinyl ketones, vinyl esters, vinyl acetates, vinyl chlorides, vinyl fluorides, vinyl ethers, vinyl pyrrolidone, acrylonitrile, methacrylnitrile, acrylamide, methacrylamide allyl acetates, fumarates, maleates, ethylenes, propylenes, tetrafluoroethylene, ethers, isobutylene, fumaronitrile, vinyl alcohols, acrylic acids, amides, carbohydrates, esters, urethanes, siloxanes, formaldehyde, phenol, urea, melamine, isoprene, isocyanates, epoxides, bisphenol A, chlorsianes, dihalides, dienes, alkyl olefins, ketones, aldehydes, vinylidene chloride, anhydrides, saccharide, acetylenes, naphthalenes, pyridines, lactams, lactones, acetals, thiiranes, episulf[iota]de, peptides, or combinations thereof. 20 . A targeting construct according to claim 1 , wherein the polymer chain is selected from polyamides, proteins, polyesters, polystyrene, polyethers, polyketones, polysulfones, polyurethanes, polysiloxanes, polysilanes, chitosan, cellulose, amylase, polyacetals, polyethylene, glycols, poly(acrylate)s, poly(methacrylate)s, poly(vinyl alcohol), poly(vinyl pyrrolidone), poly(vinylidene chloride), poly(vinyl acetate), poly(alkylene glycol)s such as poly(ethylene glycol) and poly(propylene glycol), polystyrene, polyisoprene, polyisobutylenes, poly(vinyl chloride), poly(propylene), poly(lactic acid), polyisocyanates, polycarbonates, alkyds, phenolics, epoxy resins, polysulf[iota]des, polyimides, liquid crystal polymers, heterocyclic polymers, polypeptides, polyacetylene, polyquinoline, polyaniline, polypyrrole, polythiophene, poly(p-phenylene), fluoropolymers, or combinations thereof. 21 - 73 . (canceled)
against receptors, cell surface antigens or cell surface determinants · CPC title
Single chain antibody (scFv) · CPC title
against enzymes · CPC title
against tumour-associated mucins · CPC title
against material not provided for elsewhere {, e.g. haptens, metals, DNA, RNA, amino acids} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.